Humalog – Drug Insight, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Humalog-
Drug Insight, 2019”
report has been added to ResearchAndMarkets.com’s
offering.

Humalog Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturers details across the globe along
with the location.

Scope

  • A review of the Humalog, based on information derived from company and
    industry-specific sources
  • Product details on the basis of MOA, target, dosage, route of
    administration, molecule type, strength, Chemical type and ATC
    Classification
  • Coverage of the Drug Master Files and API Manufacturers by country
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Forecasted Sales Figure from 2019-2021
  • Market competition and emerging therapies
  • SWOT Analysis

Topics Covered

1. Report Introduction

2. Humalog – Overview

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Regulatory Milestones by Region
  • Deals and Partnerships

3. Product Details

4. Humalog Sales Assessment

  • Historical Sales
  • Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

8.1 Drug 1: Company 1

  • Product Description
  • Research and Development
  • Product Development Activities

9. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/research/hkjq4s/humalog_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Endocrine
and Metabolic Disorders Drugs
, Diabetes
Drugs